力诺药包：9月20日召开董事会会议

Group 1 - Linuo Pharmaceutical announced the convening of its 13th board meeting on September 20, 2025, to review the proposal for amending the "Board Secretary Work Rules" [1] - For the first half of 2025, Linuo Pharmaceutical's revenue composition was 100.0% from the manufacturing sector [1] - As of the report date, Linuo Pharmaceutical's market capitalization was 4.3 billion yuan [1] Group 2 - Anta Sports responded to the controversy surrounding its subsidiary, Arc'teryx, which is facing issues related to "mountain blasting" [1]